Virtu Financial LLC Aptorum Group LTD Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$1.14 - $12.9 $106,936 - $1.21 Million	93,804 New	93,804 $108,000
Q1 2022 May 17, 2022	SELL	$1.22 - $2.28 $17,343 - $32,412	-14,216 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.5 - $2.64 $21,324 - $37,530	14,216 New	14,216 $21,000
Q2 2021 Sep 17, 2021	SELL	$2.37 - $3.43 $46,968 - $67,975	-19,818 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$2.45 - $4.17 $17,005 - $28,943	-6,941 Reduced 25.94%	19,818 $59,000
Q4 2020 Feb 24, 2021	BUY	$2.03 - $2.89 $54,320 - $77,333	26,759 New	26,759 $66,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $28.1M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.